Sniderman A - Search Results

1

Is the Guideline Process Replicable and, if Not, What Does This Mean?

Sniderman A, Furberg CD, Toth PP, Thanassoulis G. Sniderman A, et al. Prog Cardiovasc Dis. 2015 Jul-Aug;58(1):3-9. doi: 10.1016/j.pcad.2015.05.002. Epub 2015 May 7. Prog Cardiovasc Dis. 2015. PMID: 25958015 Review.

2

Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment.

Sniderman AD, Furberg CD, Keech A, Roeters van Lennep JE, Frohlich J, Jungner I, Walldius G. Sniderman AD, et al. Lancet. 2003 Mar 1;361(9359):777-80. doi: 10.1016/s0140-6736(03)12663-3. Lancet. 2003. PMID: 12620753 No abstract available.

3

The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk.

Walldius G, Jungner I, Aastveit AH, Holme I, Furberg CD, Sniderman AD. Walldius G, et al. Clin Chem Lab Med. 2004;42(12):1355-63. doi: 10.1515/CCLM.2004.254. Clin Chem Lab Med. 2004. PMID: 15576296

4

Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel.

Barter PJ, Ballantyne CM, Carmena R, Castro Cabezas M, Chapman MJ, Couture P, de Graaf J, Durrington PN, Faergeman O, Frohlich J, Furberg CD, Gagne C, Haffner SM, Humphries SE, Jungner I, Krauss RM, Kwiterovich P, Marcovina S, Packard CJ, Pearson TA, Reddy KS, Rosenson R, Sarrafzadegan N, Sniderman AD, Stalenhoef AF, Stein E, Talmud PJ, Tonkin AM, Walldius G, Williams KM. Barter PJ, et al. Among authors: sniderman ad. J Intern Med. 2006 Mar;259(3):247-58. doi: 10.1111/j.1365-2796.2006.01616.x. J Intern Med. 2006. PMID: 16476102 Free article.

5

Does low-density lipoprotein size add to atherogenic particle number in predicting the risk of fatal myocardial infarction?

Jungner I, Sniderman AD, Furberg C, Aastveit AH, Holme I, Walldius G. Jungner I, et al. Am J Cardiol. 2006 Apr 1;97(7):943-6. doi: 10.1016/j.amjcard.2005.10.062. Epub 2006 Feb 13. Am J Cardiol. 2006. PMID: 16563891

6

Relation of age, the apolipoprotein B/apolipoprotein A-I ratio, and the risk of fatal myocardial infarction and implications for the primary prevention of cardiovascular disease.

Sniderman AD, Holme I, Aastveit A, Furberg C, Walldius G, Jungner I. Sniderman AD, et al. Am J Cardiol. 2007 Jul 15;100(2):217-21. doi: 10.1016/j.amjcard.2007.02.086. Epub 2007 May 30. Am J Cardiol. 2007. PMID: 17631073

7

Age as a modifiable risk factor for cardiovascular disease.

Sniderman AD, Furberg CD. Sniderman AD, et al. Lancet. 2008 May 3;371(9623):1547-9. doi: 10.1016/S0140-6736(08)60313-X. Epub 2008 Mar 5. Lancet. 2008. PMID: 18321568 Review. No abstract available.

8

Why guideline-making requires reform.

Sniderman AD, Furberg CD. Sniderman AD, et al. JAMA. 2009 Jan 28;301(4):429-31. doi: 10.1001/jama.2009.15. JAMA. 2009. PMID: 19176446 No abstract available.

9

When is equal not equal?

Sniderman AD, Williams K, McQueen MJ, Furberg CD. Sniderman AD, et al. J Clin Lipidol. 2010 Mar-Apr;4(2):83-8. doi: 10.1016/j.jacl.2010.01.005. Epub 2010 Feb 1. J Clin Lipidol. 2010. PMID: 21122634

10

Why is non-high-density lipoprotein cholesterol a better marker of the risk of vascular disease than low-density lipoprotein cholesterol?

Sniderman A, McQueen M, Contois J, Williams K, Furberg CD. Sniderman A, et al. J Clin Lipidol. 2010 May-Jun;4(3):152-5. doi: 10.1016/j.jacl.2010.03.005. Epub 2010 Mar 18. J Clin Lipidol. 2010. PMID: 21122647 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

392 results

Search Page